How to buy Danaher Corporation stock (DHR)

Danaher Corporation is a diagnostics & research business based in the US. Danaher Corporation shares (DHR) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $228.55 – a decrease of 2.7% over the previous week. Danaher Corporation employs 61,000 staff and has a trailing 12-month revenue of around $23.7 billion.

Our top picks for where to buy Danaher Corporation stock

Buy Danaher Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Danaher Corporation stock price (NYSE: DHR)

Use our graph to track the performance of DHR stocks over time.

Danaher Corporation shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$228.55
52-week range	$221.83 - $281.43
50-day moving average more info button	$246.13
200-day moving average more info button	$255.29
Wall St. target price	$289.17
PE ratio more info button	43.0755
Dividend yield more info button	$1.05 (0.47%)
Earnings per share (TTM) more info button	$5.30

Is it a good time to buy Danaher Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Danaher Corporation price performance over time

Historical closes compared with the close of $226.16 from 2024-12-19

1 week (2024-12-13)	-3.72%
1 month (2024-11-21)	-3.78%
3 months (2024-09-20)	-17.05%
6 months (2024-06-21)	-11.30%

1 year (2023-12-21)	-1.82%
2 years (2022-12-21)	-1.40%
3 years (2021-12-21)	274.9541
5 years (2019-12-20)	70.23%

Is Danaher Corporation stock undervalued or overvalued?

Valuing Danaher Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Danaher Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Danaher Corporation's P/E ratio

Danaher Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, Danaher Corporation shares trade at around 43x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Danaher Corporation's PEG ratio

Danaher Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.0486. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Danaher Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Danaher Corporation's EBITDA

Danaher Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $7.5 billion.

The EBITDA is a measure of a Danaher Corporation's overall financial performance and is widely used to measure a its profitability.

Danaher Corporation financials

Revenue TTM	$23.7 billion
Operating margin TTM	20.34%
Gross profit TTM	$18.9 billion
Return on assets TTM	3.86%
Return on equity TTM	7.59%
Profit margin	16.39%
Book value	$71.03
Market Capitalization more info button	$164.9 billion

TTM: trailing 12 months

Danaher Corporation share dividends

Dividend payout ratio: 14.11% of net profits

Recently Danaher Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Danaher Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Danaher Corporation's case, that would currently equate to about $1.05 per share.

While Danaher Corporation's payout ratio might seem low, this can signify that Danaher Corporation is investing more in its future growth.

Danaher Corporation's most recent dividend payout was on 30 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 26 December 2024 (the "ex-dividend date").

Have Danaher Corporation's shares ever split?

Danaher Corporation's shares were split on a 1128:1000 basis on 1 October 2023 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1128 shares. This wouldn't directly have changed the overall worth of your Danaher Corporation shares – just the quantity. However, indirectly, the new 11.3% lower share price could have impacted the market appetite for Danaher Corporation shares which in turn could have impacted Danaher Corporation's share price.

Danaher Corporation share price volatility

Over the last 12 months, Danaher Corporation's shares have ranged in value from as little as $221.8333 up to $281.4254. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Danaher Corporation's is 0.881. This would suggest that Danaher Corporation's shares are less volatile than average (for this exchange).

Danaher Corporation overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc.

Frequently asked questions

null
What percentage of Danaher Corporation is owned by insiders or institutions?
Currently 11.003% of Danaher Corporation shares are held by insiders and 81.452% by institutions. How many people work for Danaher Corporation?
Latest data suggests 61,000 work at Danaher Corporation. When does the fiscal year end for Danaher Corporation?
Danaher Corporation's fiscal year ends in December. Where is Danaher Corporation based?
Danaher Corporation's address is: 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701 What is Danaher Corporation's ISIN number?
Danaher Corporation's international securities identification number is: US2358511028 What is Danaher Corporation's CUSIP number?
Danaher Corporation's Committee on Uniform Securities Identification Procedures number is: 235851110